For many of them, that wait is over as we can now offer the powerful efficacy of Wegovy in a once-daily pill that demonstrated about 17% weight loss, if all patients stayed on treatment," said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk
It also slows down the digestive process, which lowers appetite in most patients
doi: 10.1111/j.1742-481X.2012.01022.x 182 WolakMStaszewskaTJuszczakMGadyszyskaMBojanowskaE
This score is calculated deterministically from the forms own structure using Instafills published Form Complexity Index methodology, so it can be reproduced and independently verified it is not a subjective estimate
By removing the need for weekly injections, oral GLP-1s could significantly expand patient adoption and further intensify competition in one of the fastest-growing segments in healthcare